This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kahl, B. C.
Right arrow Articles by Herrmann, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kahl, B. C.
Right arrow Articles by Herrmann, M.

 Previous Article  |  Next Article 

Infection and Immunity, July 2005, p. 4119-4126, Vol. 73, No. 7
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.7.4119-4126.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Thymidine-Dependent Staphylococcus aureus Small-Colony Variants Are Associated with Extensive Alterations in Regulator and Virulence Gene Expression Profiles

Barbara C. Kahl,1* Gunnar Belling,1 Petra Becker,1 Indranil Chatterjee,3 Katrin Wardecki,1 Karin Hilgert,3 Ambrose L. Cheung,2 Georg Peters,1 and Mathias Herrmann3

Institute of Medical of Microbiology, University of Muenster, Muenster 48149, Germany,1 Department of Microbiology, Dartmouth Medical School, Hanover, New Hampshire,2 Institute of Medical Microbiology and Hygiene, University of Saarland Hospital and Clinics, Homburg, Germany3

Received 1 November 2004/ Returned for modification 12 January 2005/ Accepted 24 February 2005

Chronic airway infection is a hallmark of cystic fibrosis (CF) and many CF patients are infected persistently by Staphylococcus aureus. Thymidine-dependent trimethoprim-sulfamethoxazole (SXT)-resistant S. aureus small-colony variants (SCVs), often in combination with isogenic normal S. aureus phenotypes, are highly prevalent and persistent in airway secretions of CF patients due to long-term SXT therapy (B. Kahl, M. Herrmann, A. S. Everding, H. G. Koch, K. Becker, E. Harms, R. A. Proctor, and G. Peters, J. Infect. Dis. 177:1023-1029, 1998). In this report, SCVs were compared to normal S. aureus by transcription analysis of important regulator (sigB, sarA, and agr) and virulence ({alpha}-hemolysin, hla, and protein A, spa) genes. Growth curve analyses revealed longer doubling times and lower final densities for SCVs than for normal strains. sigB activity was measured by transcription analysis of the sigB target gene asp23. For nearly all SCVs, expression of all regulators was decreased as assessed by asp23 reverse transcription-PCR for sigB and Northern analysis for sarA and agr. These results are in agreement with diminished hla signals in all SCVs and increased spa signals in 5 of 10 SCVs compared to the isogenic normal S. aureus. Both supplementation of SCVs with thymidine and activation of the agr quorum-sensing system by the supernatant of the isogenic normal strain reversed transcription to almost normal levels. In conclusion, multiple changes in growth characteristics and in regulator and virulence gene expression render SCVs less virulent and allow them to survive in the hostile environment present in the airways of CF patients, thereby illustrating adaptation of the bacteria during long-term persistence.

* Corresponding author. Mailing address: Institute of Medical Microbiology, University Clinics of Muenster, Domagkstr. 10, 48149 Muenster, Germany. Phone: 49-251-835-5381. Fax: 49-251-835-5350. E-mail: kahl{at}uni-muenster.de.

Editor: V. J. DiRita

Infection and Immunity, July 2005, p. 4119-4126, Vol. 73, No. 7
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.7.4119-4126.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Nguyen, H. A., Denis, O., Vergison, A., Theunis, A., Tulkens, P. M., Struelens, M. J., Van Bambeke, F. (2009). Intracellular Activity of Antibiotics in a Model of Human THP-1 Macrophages Infected by a Staphylococcus aureus Small-Colony Variant Strain Isolated from a Cystic Fibrosis Patient: Pharmacodynamic Evaluation and Comparison with Isogenic Normal-Phenotype and Revertant Strains. Antimicrob. Agents Chemother. 53: 1434-1442 [Abstract] [Full Text]  
  • Besier, S., Zander, J., Siegel, E., Saum, S. H., Hunfeld, K.-P., Ehrhart, A., Brade, V., Wichelhaus, T. A. (2008). Thymidine-Dependent Staphylococcus aureus Small-Colony Variants: Human Pathogens That Are Relevant Not Only in Cases of Cystic Fibrosis Lung Disease. J. Clin. Microbiol. 46: 3829-3832 [Abstract] [Full Text]  
  • Kohler, C., von Eiff, C., Liebeke, M., McNamara, P. J., Lalk, M., Proctor, R. A., Hecker, M., Engelmann, S. (2008). A Defect in Menadione Biosynthesis Induces Global Changes in Gene Expression in Staphylococcus aureus. J. Bacteriol. 190: 6351-6364 [Abstract] [Full Text]  
  • Zander, J., Besier, S., Saum, S. H., Dehghani, F., Loitsch, S., Brade, V., Wichelhaus, T. A. (2008). Influence of dTMP on the Phenotypic Appearance and Intracellular Persistence of Staphylococcus aureus. Infect. Immun. 76: 1333-1339 [Abstract] [Full Text]  
  • Chatterjee, I., Kriegeskorte, A., Fischer, A., Deiwick, S., Theimann, N., Proctor, R. A., Peters, G., Herrmann, M., Kahl, B. C. (2008). In Vivo Mutations of Thymidylate Synthase (Encoded by thyA) Are Responsible for Thymidine Dependency in Clinical Small-Colony Variants of Staphylococcus aureus. J. Bacteriol. 190: 834-842 [Abstract] [Full Text]  
  • Chatterjee, I., Herrmann, M., Proctor, R. A., Peters, G., Kahl, B. C. (2007). Enhanced Post-Stationary-Phase Survival of a Clinical Thymidine-Dependent Small-Colony Variant of Staphylococcus aureus Results from Lack of a Functional Tricarboxylic Acid Cycle. J. Bacteriol. 189: 2936-2940 [Abstract] [Full Text]  
  • Besier, S., Smaczny, C., von Mallinckrodt, C., Krahl, A., Ackermann, H., Brade, V., Wichelhaus, T. A. (2007). Prevalence and Clinical Significance of Staphylococcus aureus Small-Colony Variants in Cystic Fibrosis Lung Disease. J. Clin. Microbiol. 45: 168-172 [Abstract] [Full Text]  
  • Moisan, H., Brouillette, E., Jacob, C. L., Langlois-Begin, P., Michaud, S., Malouin, F. (2006). Transcription of Virulence Factors in Staphylococcus aureus Small-Colony Variants Isolated from Cystic Fibrosis Patients Is Influenced by SigB. J. Bacteriol. 188: 64-76 [Abstract] [Full Text]  
  • Samuelsen, O., Haukland, H. H., Kahl, B. C., von Eiff, C., Proctor, R. A., Ulvatne, H., Sandvik, K., Vorland, L. H. (2005). Staphylococcus aureus small colony variants are resistant to the antimicrobial peptide lactoferricin B. J Antimicrob Chemother 56: 1126-1129 [Abstract] [Full Text]  
  • Senn, M. M., Bischoff, M., von Eiff, C., Berger-Bachi, B. (2005). {sigma}B Activity in a Staphylococcus aureus hemB Mutant. J. Bacteriol. 187: 7397-7406 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»